Find uplifting stories about heroes, innovations, and solutions
13434 results for "depression breakthrough"
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A groundbreaking psychedelic treatment just earned FDA breakthrough status after helping 77% of new moms overcome postpartum depression in a single session. This could transform care for the 1 in 5 mothers who face depression and anxiety after giving birth.
Scientists discovered a simple blood marker that predicts which depression patients will respond to the most common antidepressants, potentially sparing millions from months of trying different medications. This breakthrough could transform how doctors treat the 330 million people worldwide living with major depression.
A single dose of LSD therapy reduced depression symptoms significantly more than placebo in a late-stage clinical trial. The breakthrough brings psychedelic medicine closer to FDA approval for treating major depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
For the first time in decades, Americans with treatment-resistant depression have two powerful new options that work differently than anything before. Clinical trials show these breakthrough treatments are helping patients who've struggled for years finally find relief.
A single infusion of a controversial medication is delivering rapid relief for severe depression in just hours instead of the typical weeks or months traditional treatments require. This breakthrough could transform how doctors help patients in crisis.
Researchers discovered exactly how ketamine helps depression and created a safer alternative using three low-dose drugs. The breakthrough could help millions who don't respond to current treatments.
A second major clinical trial shows psilocybin therapy significantly reduces treatment-resistant depression. The breakthrough brings new hope to millions who haven't found relief from traditional antidepressants.
Scientists found that brain cells in young people with depression work overtime when resting but can't keep up under stress. This breakthrough could lead to earlier diagnosis and better treatments for millions struggling with the condition.
A Mobile health system just introduced a breakthrough brain therapy that helps one in three patients find complete relief from depression, even after traditional treatments failed. The noninvasive option uses magnetic pulses instead of medication.
A major clinical trial shows magnetic seizure therapy treats severe depression as effectively as electroconvulsive therapy, but with far fewer memory problems. This breakthrough could help thousands who avoid current treatments due to cognitive side effects.
Scientists tested 12 free, 10-minute online exercises on thousands of adults with depression and found two that genuinely worked a month later. The breakthrough proves mental health support doesn't always require therapy appointments or medication.
Scientists discovered that popular diabetes and weight-loss medications might fight depression by feeding helpful gut bacteria, not by acting on the brain directly. This breakthrough could lead to probiotic treatments for people battling both obesity and depression.
A brief 25-minute psychedelic treatment lifted depression symptoms that lasted up to six months for people who hadn't found relief anywhere else. Just one dose of DMT helped patients who'd been struggling for an average of 10 years.
A neuroscientist reveals that depression isn't just a chemical imbalance, and a decades-old drug could offer relief within hours instead of weeks. The discovery could transform how millions of people find help for depression.
Researchers have identified two specific brain cell types that function differently in people with depression, marking a major step toward targeted treatments. The discovery proves depression is rooted in measurable biological changes, not just emotions.
Scientists have tested a surprising new approach to treating depression by targeting inflammation instead of brain chemicals alone. In a small UK trial, an arthritis drug helped 54% of patients with hard-to-treat depression achieve remission.
Five years after taking psilocybin mushrooms with therapy, two-thirds of depression patients remain in complete remission. Even those still struggling report their depression feels far more manageable than before treatment.
A groundbreaking clinical trial shows luvesilocin, a psychedelic treatment, eliminated postpartum depression symptoms in 71% of new mothers after just one dose. The FDA has fast-tracked the drug after researchers found it works better than any existing treatment for the 1 in 5 women who suffer from postpartum depression.
Showing 20 of 13434